Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Labropoulou, Vassiliki T ^a   Skandalis, Spyros S ^b   Ravazoula, Panagiota ^a   Perimenis, Petros ^a   Karamanos, Nikos K ^b   Kalofonos, Haralabos P ^a   Theocharis, Achilleas D ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 4;

ADULT; ARTICLE; CANCER STAGING; CAPILLARY DENSITY; DISEASE ASSOCIATION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NON SEMINOMATOUS GERMINOMA; PROTEIN EXPRESSION; SEMINOMA; TESTIS GERM CELL TUMOR; TUMOR CELL; TUMOR INVASION; ADOLESCENT; AGED; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOPLASM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STROMA CELL; TESTIS TUMOR; TUMOR CELL LINE; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAINING AND LABELING; STROMAL CELLS; SYNDECAN-4; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 84880140685     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/214864     Document Type: Article

References (53)

1. Peng X., Zeng X., Peng S., Deng D., Zhang J., The association risk of male subfertility and testicular cancer: a systematic review. PloS ONE 2009 4 5 e5591 2-s2.0-68149098832 10.1371/journal.pone.0005591
2. Vidrine D. J., Hoekstra-Weebers J. E. H. M., Hoekstra H. J., Tuinman M. A., Marani S., Gritz E. R., The effects of testicular cancer treatment on health-related quality of life. Urology 2010 75 3 636 641 2-s2.0-77649182952 10.1016/j.urology.2009.09.053
3. Diéz-Torre A., Silván U., De Wever O., Bruyneel E., Mareel M., Aréchaga J., Germinal tumor invasion and the role of the testicular stroma. International Journal of Developmental Biology 2004 48 5-6 545 557 2-s2.0-5444263664 10.1387/ijdb.041897ad
4. Heidenreich A., Sesterhenn I. A., Mostofi F. K., Moul J. W., Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998 83 5 1002 1011
5. Gilbert D. C., Chandler I., Summersgill B., Mcintyre A., Missiaglia E., Goddard N. C., Huddart R. A., Shipley J., Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours. International Journal of Andrology 2011 34 4 e114 e121 2-s2.0-79960861502 10.1111/j.1365-2605.2011.01161.x
6. Milia-Argeiti E., Huet E., Labropoulou V. T., Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours. International Journal of Andrology 2012 35 6 835 844
7. Theocharis A. D., Vynios D. H., Papageorgakopoulou N., Skandalis S. S., Theocharis D. A., Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. International Journal of Biochemistry and Cell Biology 2003 35 3 376 390 2-s2.0-0037343750 10.1016/S1357-2725(02)00264-9
8. Skandalis S. S., Labropoulou V. T., Ravazoula P., Likaki-Karatza E., Dobra K., Kalofonos H. P., Karamanos N. K., Theocharis A. D., Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. BMC Cancer 2011 11 article 314 2-s2.0-79960668857 10.1186/1471-2407-11-314
9. Theocharis A. D., Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochimica et Biophysica Acta 2002 1588 2 165 172 2-s2.0-0037145715 10.1016/S0925-4439(02) 00161-8
10. Tímár J., Lapis K., Dudás J., Sebestyén A., Kopper L., Kovalszky I., Proteoglycans and tumor progression: janus-faced molecules with contradictory functions in cancer. Seminars in Cancer Biology 2002 12 3 173 186 2-s2.0-0035988837 10.1016/S1044-579X(02)00021-4
11. Theocharis A. D., Skandalis S. S., Tzanakakis G. N., Karamanos N. K., Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS Journal 2010 277 19 3904 3923 2-s2.0-77956641177 10.1111/j.1742-4658.2010.07800.x
12. Labropoulou V. T., Theocharis A. D., Ravazoula P., Perimenis P., Hjerpe A., Karamanos N. K., Kalofonos H. P., Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours. Histopathology 2006 49 6 582 593 2-s2.0-33845535432 10.1111/j.1365-2559.2006.02558.x
13. Couchman J. R., Transmembrane signaling proteoglycans. Annual Review of Cell and Developmental Biology 2010 26 89 114 2-s2.0-78049404922 10.1146/annurev-cellbio-100109-104126
14. 3 integrins in human breast carcinoma cells. Experimental Cell Research 2003 286 2 219 232 2-s2.0-0037622031 10.1016/S0014-4827(03)00126-5
15. Clasper S., Vekemans S., Fiore M., Plebanski M., Wordsworth P., David G., Jackson D. G., Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. Journal of Biological Chemistry 1999 274 34 24113 24123 2-s2.0-0033588102 10.1074/jbc.274.34.24113
16. Mundhenke C., Meyer K., Drew S., Friedl A., Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. American Journal of Pathology 2002 160 1 185 194 2-s2.0-0036144193
17. O'Connell M. P., Fiori J. L., Kershner E. K., Frank B. P., Indig F. E., Taub D. D., Hoek K. S., Weeraratna A. T., Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells. Journal of Biological Chemistry 2009 284 42 28704 28712 2-s2.0-70350399516 10.1074/jbc.M109.028498
18. Carvallo L., Muñoz R., Bustos F., Escobedo N., Carrasco H., Olivares G., Larraín J., Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4. Journal of Biological Chemistry 2010 285 38 29546 29555 2-s2.0-77956538049 10.1074/jbc.M110.155812
19. Brule S., Friand V., Sutton A., Baleux F., Gattegno L., Charnaux N., Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells. Biochimica et Biophysica Acta 2009 1790 12 1643 1650 2-s2.0-71549123983 10.1016/j.bbagen.2009.08.001
20. Charni F., Friand V., Haddad O., Hlawaty H., Martin L., Vassy R., Oudar O., Gattegno L., Charnaux N., Sutton A., Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochimica et Biophysica Acta 2009 1790 10 1314 1326 2-s2.0-69949094934 10.1016/j.bbagen.2009.07.015
21. 1 integrin and MT1-MMP. Matrix Biology 2011 30 3 207 217 2-s2.0-79955547444 10.1016/j.matbio.2011.03.003
22. Bouskine A., Vega A., Nebout M., Benahmed M., Fénichel P., Expression of embryonic stem cell markers in cultured JKT-1, a cell line derived from a human seminoma. International Journal of Andrology 2010 33 1 54 63 2-s2.0-74349130363 10.1111/j.1365-2605.2009.00950.x
23. Baba F., Swartz K., Van Buren R., Eickhoff J., Zhang Y., Wolberg W., Friedl A., Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype. Breast Cancer Research and Treatment 2006 98 1 91 98 2-s2.0-33745898538 10.1007/s10549-005- 9135-2
24. Lendorf M. E., Manon-Jensen T., Kronqvist P., Multhaupt H. A. B., Couchman J. R., Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma. Journal of Histochemistry and Cytochemistry 2011 59 6 615 629 2-s2.0-79960925887 10.1369/0022155411405057
25. Kousidou O. C., Berdiaki A., Kletsas D., Zafiropoulos A., Theocharis A. D., Tzanakakis G. N., Karamanos N. K., Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells. Molecular Oncology 2008 2 3 223 232 2-s2.0-51449094588 10.1016/j.molonc.2008.06.002
26. Nikolova V., Koo C.-Y., Ibrahim S. A., Wang Z., Spillmann D., Dreier R., Kelsch R., Fischgräbe J., Smollich M., Rossi L. H., Sibrowski W., Wülfing P., Kiesel L., Yip G. W., Götte M., Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis 2009 30 3 397 407 2-s2.0-62349114465 10.1093/carcin/bgp001
27. Kato M., Saunders S., Nguyen H., Bernfield M., Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Molecular Biology of the Cell 1995 6 5 559 576 2-s2.0-0029005076
28. Leppa S., Vleminckx K., Van Roy F., Jalkanen M., Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. Journal of Cell Science 1996 109 6 1393 1403 2-s2.0-0029973078
29. Anttonen A., Kajanti M., Heikkilä P., Jalkanen M., Joensuu H., Syndecan-1 expression has prognostic significance in head and neck carcinoma. British Journal of Cancer 1999 79 3-4 558 564 2-s2.0-0032903593 10.1038/sj.bjc.6690088
30. Wiksten J. P., Lundin J., Nordling S., Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. International Journal of Cancer 2001 95 1 1 6
31. Fujiya M., Watari J., Ashida T., Honda M., Tanabe H., Fujiki T., Saitoh Y., Kohgo Y., Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Japanese Journal of Cancer Research 2001 92 10 1074 1081 2-s2.0-0034758184
32. Klatka J., Syndecan-1 expression in laryngeal cancer. European Archives of Oto-Rhino-Laryngology 2002 259 3 115 118 2-s2.0-0036202534 10.1007/s00405-001-0429-7
33. Harada K., Masuda S., Hirano M., Nakanuma Y., Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma. Human Pathology 2003 34 9 857 863 2-s2.0-0141763880 10.1016/S0046-8177(03)00336-8
34. Kumar-Singh S., Jacobs W., Dhaene K., Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. Journal of Pathology 1998 186 3 300 305
35. Matsumoto A., Ono M., Fujimoto Y., Gallo R. L., Bernfield M., Kohgo Y., Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. International Journal of Cancer 1997 74 5 482 491
36. Shah L., Walter K. L., Borczuk A. C., Kawut S. M., Sonett J. R., Gorenstein L. A., Ginsburg M. E., Steinglass K. M., Powell C. A., Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Cancer 2004 101 7 1632 1638 2-s2.0-4844220814 10.1002/cncr.20542
37. Woods A., Couchman J. R., Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Molecular Biology of the Cell 1994 5 2 183 192 2-s2.0-0028213641
38. Woods A., Couchman J. R., Syndecan-4 and focal adhesion function. Current Opinion in Cell Biology 2001 13 5 578 583 2-s2.0-0035479818 10.1016/S0955-0674(00)00254-4
39. Rapraeger A. C., Syndecan-regulated receptor signaling. Journal of Cell Biology 2000 149 5 995 997 2-s2.0-0034729437 10.1083/jcb.149.5.995
40. Woods A., Longley R. L., Tumova S., Couchman J. R., Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Archives of Biochemistry and Biophysics 2000 374 1 66 72 2-s2.0-0034142030 10.1006/abbi.1999.1607
41. Wilcox-Adelman S. A., Denhez F., Goetinck P. F., Syndecan-4 modulates focal adhesion kinase phosphorylation. Journal of Biological Chemistry 2002 277 36 32970 32977 2-s2.0-0037031817 10.1074/jbc.M201283200
42. Cary L. A., Chang J. F., Guan J.-L., Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. Journal of Cell Science 1996 109 7 1787 1794 2-s2.0-0029948080
43. Saoncella S., Echtermeyer F., Denhez F., Nowlen J. K., Mosher D. F., Robinson S. D., Hynes R. O., Goetinck P. F., Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 2805 2810 2-s2.0-0033017955 10.1073/pnas.96.6.2805
44. Lim S.-T., Longley R. L., Couchman J. R., Woods A., Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C α (PKC α) increases focal adhesion localization of PKC α Journal of Biological Chemistry 2003 278 16 13795 13802 2-s2.0-0037515626 10.1074/jbc.M208300200
45. Oh E.-S., Woods A., Couchman J. R., Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. Journal of Biological Chemistry 1997 272 13 8133 8136 2-s2.0-0030889054 10.1074/jbc.272.13.8133
46. Horowitz A., Tkachenko E., Simons M., Fibroblast growth factor-specific modulation of cellular response by syndecan-4. Journal of Cell Biology 2002 157 4 715 725 2-s2.0-0037071542 10.1083/jcb.200112145
47. Chalkiadaki G., Nikitovic D., Berdiaki A., Sifaki M., Krasagakis K., Katonis P., Karamanos N. K., Tzanakakis G. N., Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism. International Journal of Biochemistry and Cell Biology 2009 41 6 1323 1331 2-s2.0-60349109301 10.1016/j.biocel.2008.11.008
48. Longley R. L., Woods A., Fleetwood A., Cowling G. J., Gallagher J. T., Couchman J. R., Control of morphology, cytoskeleton and migration by syndecan-4. Journal of Cell Science 1999 112 20 3421 3431 2-s2.0-0032700971
49. Midwood K. S., Mao Y., Hsia H. C., Valenick L. V., Schwarzbauer J. E., Modulation of cell-fibronectin matrix interactions during tissue repair. Journal of Investigative Dermatology Symposium Proceedings 2006 11 1 73 78 2-s2.0-33748785164 10.1038/sj.jidsymp.5650005
50. Stanley M. J., Stanley M. W., Sanderson R. D., Zera R., Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. American Journal of Clinical Pathology 1999 112 3 377 383 2-s2.0-0033491136
51. Mennerich D., Vogel A., Klaman I., Dahl E., Lichtner R. B., Rosenthal A., Pohlenz H.-D., Thierauch K.-H., Sommer A., Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. European Journal of Cancer 2004 40 9 1373 1382 2-s2.0-2942575983 10.1016/j.ejca.2004.01. 038
52. Maeda T., Alexander C. M., Friedl A., Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Research 2004 64 2 612 621 2-s2.0-1642515775 10.1158/0008-5472.CAN-03- 2439
53. Maeda T., Desouky J., Friedl A., Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene 2006 25 9 1408 1412 2-s2.0-33644764714 10.1038/sj.onc.1209168